The heritage American brand recently regained the copyrights for vintage patterns from the ‘60s, ‘70s, and ‘80s, and showed them off in modern fashion in Key West.

Decades before the phrases “the Kate effect” and “the Meghan effect” became shorthand for the economic impact Kate Middleton and Meghan Markle can drive via their outfit choices, there was a ...

Disney and Lilly Pulitzer released a new collaboration in time for the holiday season. See the collection, what it will cost you.

My favorite thrift find of 2025 was undoubtedly a vintage Lilly Pulitzer dress, a gift to my little sister for her homecoming dance. Two months later, I shared my thrifting success with Lilly Pulitzer ...

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eli Lilly achieved a $1 trillion market cap, a healthcare first, ...

Nov 21 (Reuters) - Eli Lilly (LLY.N), opens new tab hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its ...

Eli Lilly on Monday, Dec. 1 slashed prices of its blockbuster weight loss drug Zepbound for consumers who buy the prescription medication directly from the drugmaker. Lilly's price cuts ranged from ...

The world’s largest drugmaker, Eli Lilly & Co., just notched another milestone: it’s the first health-care company to cross the $1 trillion threshold as investors bet big on the drugmaker’s ...

"The cloud that has been casting a shadow over the healthcare industry is slowly lifting. The Eli Lilly agreement, along with the Trump deal with Pfizer last month, is providing investors with much ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more ...

Eli Lilly stock has soared in the triple digits over three years. Investors are excited about the company’s portfolio of weight loss drugs, which has generated blockbuster revenue. The stock recently ...

Eli Lilly delivered 54% revenue growth in Q3 2025, raised full-year guidance, and remains a defensive haven amid market volatility. LLY's obesity and diabetes franchise, led by Zepbound, Mounjaro, and ...